Ruling 'denies treatment to 100,000 Alzheimer's patients' - The Telegraph 15th April 2008

Almost 100,000 Alzheimer's patients face being denied NHS treatment which could delay the onset of their disease, the Court of Appeal was told yesterday. Sufferers are being refused a potentially life changing drug because the Government's medicines watchdog has ruled that it is not "cost effective" in the early stages. The National Institute for Health and Clinical Excellence (Nice) ruled four years ago that the drug Aricept, which costs £2.50 a day, as well as two others, Reminyl and Exelon, were too expensive except for patients whose condition had deteriorated.

Link to Article